Show source-provided references
8. Distinctive bone regeneration of calvarial defects using biphasic calcium phosphate supplemented ultraviolet-crosslinked collagen membrane
10.5051/jpis.2020.50.1.14 ↗9. BMP-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration
10.1002/jbm.a.35282 ↗14. Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic, part II (BMP delivery)
10.1002/term.74 ↗15. Bone morphogenetic proteins in tissue engineering: The road from the laboratory to the clinic, part I (basic concepts)
10.1002/term.63 ↗16. Gkiliopoulos, D., Tsamesidis, I., Theocharidou, A., Pouroutzidou, G.K., Christodoulou, E., Stalika, E., Xanthopoulos, K., Bikiaris, D., Triantafyllidis, K., and Kontonasaki, E. (2022). SBA-15 mesoporous silica as delivery vehicle for rhBMP-2 bone morphogenic protein for dental applications. Nanomaterials, 12.
10.3390/nano12050822 ↗18. Evaluation of different combinations of biphasic calcium phosphate and growth factors for bone formation in calvarial defects in a rabbit model
10.11607/prd.2633 ↗20. Microcomputed tomography and histological study of bone regeneration using tooth biomaterial with BMP-2 in rabbit calvarial defects
10.1155/2021/6690221 ↗21. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A Pilot Study
10.1902/jop.2001.72.5.651 ↗22. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers
25. Controlled release of BMP-2 using a heparin-conjugated carrier system reduces in vivo adipose tissue formation
10.1002/jbm.a.35207 ↗26. Reduction of adipose tissue formation by the controlled release of BMP-2 using a hydroxyapatite-coated collagen carrier system for sinus-augmentation/extraction-socket grafting
10.3390/ma8115411 ↗27. Bone morphogenetic protein-2 and vascular endothelial growth factor in bone tissue regeneration: New insight and perspectives
10.1111/os.12112 ↗29. Guided bone regeneration in standardized calvarial defects in rats using bio-oss and β-tricalcium phosphate with adjunct platelet-derived growth factor therapy: A real-time in vivo microcomputed tomographic, biomechanical, and histologic analysis
10.11607/prd.2265 ↗30. Real-time assessment of guided bone regeneration in standardized calvarial defects using a combination of bone graft and platelet-derived growth factor with and without collagen membrane: An in vivo microcomputed tomographic and histologic experiment in rats
10.11607/prd.2277 ↗33. Injectable BMP-2 delivery system based on collagen-derived microspheres and alginate induced bone formation in a time- and dose-dependent manner
10.22203/eCM.v035a17 ↗34. Addition of a synthetically fabricated osteoinductive biphasic calcium phosphate bone graft to BMP2 improves new bone formation
10.1111/cid.12384 ↗36. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: A pilot study
37. Is the tunnel technique more effective than open augmentation with a titanium-reinforced polytetrafluoroethylene membrane for horizontal ridge augmentation?
10.1016/j.joms.2016.04.031 ↗38. Comparative study of three different membranes for guided bone regeneration of rat cranial defects
10.1054/ijom.2000.0011 ↗41. Bone regeneration with recombinant human bone morphogenetic protein-2 (rhBMP-2) using absorbable collagen sponges (ACS): Influence of processing on ACS characteristics and formulation
10.1081/PDT-100101374 ↗42. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration
10.1002/bit.10906 ↗43. Comparison of collagen membrane and bone substitute as a carrier for rhBMP-2 in lateral onlay graft
10.1111/clr.12320 ↗44. Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: An immunohistochemical study in dogs